ALBANY MOLECULAR Stock – Fundamental Analysis
Not enough price data available yet.
Fundamental Data & Ratios (Balance sheet update: 3/16/2017)
| Balance Sheet | Total Assets | 1,209,650,000.00 | ROE | – |
| Balance Sheet | Total Equity | 298,982,000.00 | ROA | – |
| Cashflow | Capital Expenditures | -52,000,000.00 | P/FCF | – |
| Cashflow | Free Cash Flow | -25,365,000.00 | – | – |
| Cashflow | Operating Cash Flow | 26,635,000.00 | P/CF | – |
| Income | Earnings per Share (diluted) | -1.83 | Div. Yield | – |
| Income | Net Income | -70,171,000.00 | P/E | – |
| Income | Shares Outstanding | 38,304,000.00 | P/B | – |
| Income | Total Revenue | 570,450,000.00 | P/S | – |
Ratios calculated on: –
Company Description
Albany Molecular Research, Inc. is a global contract research and manufacturing company. The Company provides drug discovery, development, and manufacturing services. The Company operates through three segments: Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API) and Drug Product Manufacturing (DPM). The DDS segment includes activities, such as drug lead discovery, optimization, drug development and small-scale commercial manufacturing. API includes pilot to commercial scale manufacturing of active pharmaceutical ingredients and intermediates and high potency and controlled substance manufacturing. DPM includes pre-formulation, formulation and process development through commercial scale production of complex liquid-filled and lyophilized injectable formulations. It supplies a range of services and technologies supporting the discovery and development of pharmaceutical products, the manufacturing of API and drug product for new and generic drugs.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.amriglobal.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more